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ABSTRACT
Introduction. Lung tranplantation, a consolidated treatment for end-stage lung disease,
utilizes preservation solutions, such as low potassium dextran (LPD), to mitigate ischemia–
reperfusion injury. We sought the local development of LPD solutions in an attempt to
facilitate access and enhance usage. We also sought to evaluate the effectiveness of a
locally manufactured LPD solution in a rat model of ex vivo lung perfusion.
Methods. We randomized the following groups \?\adult of male Wistar rats (n  25
each): Perfadex (LPD; Vitrolife, Sweden); locally manufactured LPD-glucose (LPDnac)
(Farmoterapica, Brazil), and normal saline solution (SAL) with 3 ischemic times (6, 12,
and 24 hours). The harvested heart–lung blocks were flushed with solution at 4°C. After
storage, the blocks were connected to an IL-2 Isolated Perfused Rat or Guinea Pig Lung
System (Harvard Apparatus) and reperfused with homologous blood for 60 minutes.
Respiratory mechanics, pulmonary artery pressure, perfusate blood gas analysis, and lung
weight were measured at 10-minute intervals. Comparisons between groups and among
ischemic times were performed using analysis of variance with a 5% level of significance.
Results. Lungs preserved for 24 hours were nonviable and therefore excluded from the
analysis. Those preserved for 6 hours showed better ventilatory mechanics when compared
with 12 hours. The oxygenation capacity was not different between lungs flushed with LPD
or LPDnac, regardless of the ischemic time. SAL lungs showed higher PCO2 values than the
other solutions. Lung weight increased over time during perfusion; however, there were no
significant differences among the tested solutions (LPD, P  .23; LPDnac, P  .41; SAL,
P .26). We concluded that the LPDnac solution results in gas exchange were comparable
to the original LPD (Perfadex); however ventilatory mechanics and edema formation were
better with LPD, particularly among lungs undergoing 6 hours of cold ischemia.
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CEP 05403-000, São Paulo, SP, Brazil. E-mail: paulopego@LUNG transplantation, an established treatment forend-stage lung disease, depends upon preservation for
long distance organ procurement. The most common cur-
rent preservation methods use hypothermic solutions deliv-
ered directly into the pulmonary vasculature.1 For develop-
ment of lung preservation solutions, small animal models
are both useful and cost effective before applications in
large animals or humans. Our isolated ex vivo lung perfu-
sion system uses rat heart–lung blocks with homologous
blood priming the system.2
Celsior and low-potassium dextran (LPD) are among the
most popular preservation solutions for clinical lung trans-
plantation. Until recently, both solutions were not manu- incor.usp.br
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PERFADEX VERSUS LPD 85factured in Brazil, thus generating difficulties inherent to
imported goods in regard to cost and availability. LPD
solution (Perfadex, Vitrolife, Sweden) which was developed
2 decades ago,3–5 is used in lung transplant centers in Brazil,
and is now being manufactured in Brazil. Before its wide-
spread clinical domestic use, we sought to test its perfor-
mance versus Perfadex as a benchmark, using an ex vivo
isolated rat lung perfusion system.
MATERIALS AND METHODS
Male Wistar rats weighing 250–350 g were anesthetized with
sodium thiopental (50 mg/kg, intraperitoneally) before placing a
tracheostomy and instituting mechanical ventilation (room air,
RR  70 bpm, PEEP  1 cm H2O; “IL-2 - Isolated Perfused Rat
or Guinea Pig Lung System” Harvard Apparatus, Holliston, Mass;
Hugo Sachs Elektronik, Alemanha). The animal was heparinized
(1500 IU) via the inferior vena cava that had been exposed through
a sternolaparotomy. The diaphragm was opened radially, the
inferior pulmonary ligament severed, and the inferior vena cava
isolated above the diaphragm. A small incision was made in the
right ventricle outflow tract adjacent to the pulmonary artery,
the inferior vena cava was severed close to the heart, and a
drainage longitudinal incision was made in apex of the left ventri-
cle. The animals were then randomized to receive one of the
preservation solutions: Perfadex (LPD; Vitrolife-Sweden); domes-
tic LPD (LPDnac; Farmoterapica, São Paulo) or 0.9% saline,
(Baxter Hospitalar Inc.; São Paulo; normal saline, SAL). Via an
indwelling pulmonary artery cannula placed through the right
ventricle incision, we performed an an\?\egrade pulmonary flush
with one of the cold (4°C) solutions under a pressure of 10 cm H2O.
he trachea was ligated at the end of the flush; the lungs were kept
yperinflated during storage.6 A more detailed description of the
rocedure has been published elsewhere.7,8 The investigators were
linded to the solution.
Seventy-five heart–lung blocks were distributed into 3 groups
n  25 each), according to the preservation solution. For each
olution, the heart–lung blocks underwent cold storage periods of
(n  10), 12 (n  10) or 24 hours (n  5).
Aproximately 30 minutes before starting the perfusion, blood
from 3 anesthetized, heparinized donor rats was drawn by inferior
vena caval puncture and stored at 37°C. Blood was diluted in
normal saline (1:1) to obtain 75–80 mL with an hematocrit between
15% and 20%. The ex vivo lung perfusion system circuit was
primed and recirculated for 10 minutes through a membrane
deoxygenator (D-150 Hemofilter, Medsulfone, Italy) using a mix-
ture of 90% N2 and 10% CO2. The heart–lung block was prepared
n a side table. The tracheal cannula was positioned and a left
trial cannula passed though the previous left ventriculotomy was
dvanced into the left atrial appendage. Both cannulae were fixed
ith nonabsorbable sutures and the heart–lung block connected to
he system.7 The negative pressure chamber was then closed and
the perfusion started slowly along with the ventilation (Fig 1). The
blood flow was increased stepwise parallel to the ventilation, to
achieve stable parameters by 10 minutes: ventilation-RR  60
bpm; inspiration/expiration ratio  60%; 1 sigh/minute with a 50%
increment of tidal volume. The tidal volume was increased to reach
10 mL/kg donor rat body weight. Perfusion progressed concomi-
tantly to achieve flows of 5–7 mL/min. After ventilation and
perfusion were stable for approximately 10 minutes, data collection
started at 10 minute intervals for 60 minutes, including pulmonary
artery pressure and ventilatory mechanics—tidal volume, maxi-mum and minimum pleural pressures, resistance, compliance, and
conductance. Blood samples were drawn from the pulmonary
arterial and left atrial lines for hematocrit and blood gas analysis
(ABL 800, Radiometer, Denmark). The hematocrit of the perfus-
ate was maintained between 18% and 19% in all groups and
ischemic times. Relative oxygenation capacity (ROC) was
calculated using the formula proposed by Wittwer et al9; ROC 
(PvO2  PaO2)  100]/PaO2, in which PaO2 was the deoxygenated
blood drawn from the pulmonary artery line, and PvO2 is the PO2
measured in the effluent of the left atrial cannula. At the end of the
perfusion, the block was removed, the cannulae withdrawn, the left
lung divided into 4 fragments of the upper lobe for future electron
microscopic analysis, and the remnant left lung weighed before
(wet lung weight) and after storage at 70–80°C (dry lung weight) to
obtain the wet/dry lung ratio. The right lung was preserved in
formalin for future histologic analysis.
Statistical Analysis
Data were analyzed using a statistical package (SPSS 13.0 for
Windows; SPSS Inc., Chicago, Ill, EUA), employing repeated
measures analysis of variance for preservation solution, and isch-
Fig 1. Harvard Apparatus - IL-2 - Isolated Perfused Rat or
Guinea Pig Lung System. (A) System filled with blood during
recirculation. (B) Negative pressure chamber containing heart-
lung block.emic and perfusion times. Mutiple comparisons were performed
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86 SOARES, BRAGA, NEPOMUCENO ET ALwith the Bonferroni test. For those parameters that were not
normally distributed, we used Kruskal–Wallis and Mann–Whitney
nonparametric tests. The level of significance was set at P  .05.
RESULTS
The average body weight of the donor animals—295 
12 g—was not significantly different among the groups.
Regardless of the preservation solution, all lungs pre-
served for 24 hours were nonviable and grossly edema-
tous, flooding the ventilation system within the first
minutes of perfusion, thus hampering data collection. We
thus excluded this group from the analysis, which was
limited to the 6- and 12-hour cold ischemia cohorts. All
optical and electron microscopic samples will be pro-
cessed at a later date and therefore, are not included in
this report.
Maximum inspiratory flow was significantly higher in
lungs preserved for 6 hours with LPD and SAL (P  .003
nd P .001, respectively). On the other hand, the LPDnac
ungs did not show any significant differences between the
schemic times (P  .304).
Tidal volume was not different between 6 and 12 hours of
schemia across the groups (6 hours, P  .507; 12 hours,
 .459). Tidal volume was higher in LPD and SAL lungs
preserved for 6 hours (P  .003 and P  .001, respectively),
compared with the 12-hour lungs. Conversely, lungs pre-
served with LPDnac either for 6 or for 12 hours did not
show significant differences: 1.8 0.2 mL and 1.4 0.3 mL,
respectively (P  .304).
Pulmonary resistance was greater in all lungs preserved
for 12 hours, regardless of the flush solution (LPD, P 
.0001; LPDnac, P  .002; SAL, P  .006). Compared with
12 hours, lung compliance was greater in LPD and SAL
lungs preserved for 6 hours (P  .008 and P  .006,
respectively). Conversely, lungs preserved with LPDnac did
not show differences between the ischemic times in regard
to compliance (P  .238).
The ROC was higher only in the SAL lungs preserved for
6 if compared with 12 hours (P  .001). However, in this
group a decline in ROC was observed during the 60 minutes
of perfusion. We observed no differences in ROC between
LPD and LPDnac lungs preserved for 6 or 12 hours (P 
.052 and P  .703, respectively; Fig 2). In fact, when all
preservation solutions were compared, no differences were
found between 6 and 12 hours of ischemia with regard to
ROC (6 hours, P  .137; 12 hours, P  .256).
The effluent deoxygenated blood PaCO2 from the mem-
rane showed no differences between the groups. Nonethe-
ess, the 12-hour LPD lungs showed a significantly higher
ulmonary arterial PaCO2 (6 hours  39  2 mm Hg versus
2 hours  51  3 mm Hg; P  .01), as did the SAL lungs
6 hours  48  3 mm Hg versus 12 hours  61  2.8 mm
g; P  .003). There were no differences between ischemic
imes in LPDnac lungs (6 hours 44 2.8 mm Hg versus 12
ours  30  4 mm Hg; P  .271). The PvCO2 followed the
endency of the pulmonary arterial PaCO2; it was higher in the12-hour lungs. SAL lungs, which showed the highest PaCO2,were different between the ischemic times (6 hours 30 3.2
mm Hg versus 12 hours  48  3 mm Hg; P  .0001),
followed by LPD (6 hours  24  3.2 mm Hg versus 12
ours  38  3 mm Hg; P  .006). There were no
significant differences in PvCO2 between the 2 ischemic
imes among the LPDnac lungs, which was maintained at
hysiological levels (6 hours  33  3 mm Hg versus 12
hours  35  4.3 mm Hg; P  .735).
The pulmonary arterial pressure was not different be-
tween the groups with regard to the ischemic times (6 hours
P  .702; 12 hours P  .762) or preservation solutions
(LPD, P .154; LPDnac, P .263; SAL, P .173). During
the 60-minute perfusion time, a rise in pulmonary arterial
pressure was recorded in LPD lungs at both ischemic times
as well as in SAL lungs undergoing 12 hours of ischemia,
whereas the LPDnac lungs did not show a measureable
increase in pulmonary arterial pressures.
Lung weight increased gradually during perfusion. It was
significant in lungs preserved with LPDnac for 6 hours and
SAL preserved for 12 hours. There were no differences
among lung preservation solutions (LPD, P  .23; LPDnac,
P  .41; SAL, P  .26).
The wet/dry weight ratio of the lungs was significantly
smaller in lungs at 6 hours of ischemia (6 hours  3.89 
0.23 g versus 12 hours  4.89  0.24 g), being more
prominent in LPD lungs (6 hours  3.3  0.41 g versus 12
hours  5.45  0.39 g; P  .001; Fig 3).
DISCUSSION
Lung preservation has ultimately allowed distant organ
Fig 2. Relative oxygenation capacity during perfusion in all
preservation solution groups showing no significant differences
between LPD and LPDnac regardless of the ischemic time. (A)
Six hours of cold ischemia. (B) Twelve hours of cold ischemia.retrieval and reduced postischemic reperfusion injury, an
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PERFADEX VERSUS LPD 87important limitation in graft viability after transplantation
and an adjuvant to the development of bronchiolitis oblit-
erans.10 The commonly utilized lung preservation methods
nclude hypothermia associated with the administration of
ush solutions supplemented by pulmonary vasodila-
ors.11,12 The LPD solution was conceived for lung preser-
ation almost 2 decades ago3,4; nevertheless, its clinical
ntroduction has been gradual, despite its apparent superi-
rity to other preservation solutions.13
The development of preservation solutions dedicated to
the lung has decreased the rate of acute graft dysfunction
from 30% to 15%.14 Despite such evidence, there remains
debate regarding the benefits of LPD solution and its
mpact on 1-year mortality after lung transplantation.15
Recently with the advent of ex vivo lung reconditioning16
and postcardiocirculatory arrest,17 current lung preserva-
tion strategies and solutions are undergoing a reassessment.
Lung transplant centers in Brazil must import LPD,
which adds to the cost and poses a strategic, nonmedical
issue to the already complex and technically demanding
character of lung transplantation. Therefore, the develop-
ment of a locally manufactured solution similar to LPD is
both desirable and needed.
We used an ex vivo rat lung perfusion model to test the
performance of the locally manufactured LPD solution
(LPDnac). This perfusion system requires fewer resources,
and is faster as well as easier than large animal models. We
have employed this model to study lung mechanics and
preservation using homologous blood.2 As opposed to
others who proposed the use of bovine blood,18 we have
been able to obtain consistent results with a 1:1 dilution of
blood with normal saline, thus reducing the number of
donor animals to 2–3 per perfusion, depending on weight.
We also observed that the hemodilution did not alter the
gas exchange or the hemodynamics significantly, yielding
equally reliable results. Nonetheless, we acknowledge that
edema formation as detected by the increased lung weight
during perfusion may be somewhat influenced by the he-
modilution.
In the present study, we observed that lungs preserved for
24 hours were nonviable, regardless of the solution. The
reason for this limitation is probably related more to the
Fig 3. Wet/dry weight ratio of the lungs during perfusion in all
preservation solution to 6 and 12 hours, showing significant
differences in LPD lungs (P  .001).model itself than to the time or the preservation solution. Inhe past, this problem has been addressed with parabiotic
erfusion, a system in which an animal is connected in
arallel to the circuit to act as a deoxygenator. This
echnique has achieved viable lungs with up to 18 hours of
old ischemia.19 We believe that other factors in our model,
such as nonpulsatile flow, the presence of foreign surfaces
for the blood, the use of deoxygenated blood, and even the
membrane itself may have contributed to render the 24-
hour lungs nonviable. In contrast, all lungs preserved for 6
or 12 hours in this study provided consistent data. Such
ischemic times are actually closer to the clinical scenario, as
opposed to previous studies in a similar model wherein the
ischemic times were restricted to 2 to 4 hours.9,18
Lungs preserved for 6 hours in the LPD and SAL groups
showed better function with respect to ventilatory mechan-
ics, which was possibly the result of a lesser ischemic insult.
In contrast, the lungs preserved with LPDnac did not follow
this pattern. The absence of differences in mechanics at
both ischemic times suggests that the LPDnac solution does
not confer the same protection against longer ischemic
times. Airway resistance was greater in all 12-hour lungs
regardless of the group, which conforms with the assump-
tion that longer ischemic times impose more lung injury,
resulting in edema formation and consequently increased
airway resistance.
We included SAL group to assess the stability and
reliability of the model. Because SAL is not a preservation
solution, it has a tendency to produce edema and poor
function. Indeed, as we anticipated the SAL group results at
12 hours were consistently worse compared with other
solutions at the same ischemic time. However, as opposed
to our expectations, 6-hour SAL lungs showed better me-
chanics and gas exchange, although the oxygenation had
declined, particularly during the last half of the perfusion.
The ROC did not reveal differences when we compared
the preservation solutions and the ischemic times. SAL was
the only group that showed slightly better gas exchange at 6
hours of ischemia, despite its decline during perfusion.
Similar to the ventilatory mechanics, the differences in
ROC among the SAL group may also be attributed to
hemodilution. Hemodilution and its beneficial effects in
ischemia–reperfusion injury have been described in detail
by Puskas et al20 using a similar model of ex vivo perfusion
n which hemodilution with crystalloid solution improved
ostischemic reperfusion injury. We therefore hypothesized
hat in our study hemodilution may have been greater in the
AL group because those lungs already had saline in the
ascular bed upon imitiation of perfusion with diluted
lood. This situation may have triggered the changes in
echanics and gas exchange that we observed in the 6-hour
schemic lungs, in addition to the absence of a cross-
irculation and the presence of a deoxygenator.
The reliability and stability of the deoxygenator were
epresented by the constant PaCO2 levels observed during
he experiments. Meanwhile, the increase in PvCO2 levels
observed in both the LPD and SAL cohorts at 12 hours
together with the absence of differences between the isch-
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other evaluated parameters.
The increased weight of the heart–lung blocks observed
in LPDnac and SAL groups may reflect reperfusion injury
and edema, although hemodilution and nonpulsatile flow
are potential adjuvants to the process. The wet/dry weight
ratio has long been employed as an indirect but reliable
index of lung edema, reperfusion injury, preservation qual-
ity,21 and alveolar injury.22,23 Lungs undergoing 6 hours of
schemia showed less edema as shown by the wet/dry weight
atios. Less edema has been a hallmark of the LPD solution
ince its conception, probably because of its extracellular
haracteristics, which mitigate edema formation regadless
f the direction that the lungs are flushed—antegrade24 or
retrograde25,26—resulting in better performance.
We concluded that, in this ex vivo lung perfusion model
sing rat heart–lung blocks, the LPD solution manufac-
ured domestically yielded comparable gas exchange to the
riginal LPD (Perfadex). However, the ventilation mechan-
cs and edema formation were still better with LPD, partic-
larly in lungs undergoing 6 hours of cold ischemia.
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